Skip to main content
The V600E BRAF mutation is associated with poorer prognosis and increased risk of recurrence in patients who have undergone resection of colorectal…
Survivors of breast cancer are not getting the recommended level of screening post-surgery.
Chimeric antigen receptor T-cell therapy is effective in a certain group of patients with B-cell acute lymphoblastic leukemia.
Oncology Newswatch is providing coverage of a number of topics discussed at the 2018 ASCO Annual Meeting.
Multiparameter flow cytometric minimal residual disease can improve outcome stratification and redefine partial response in patients with acute…
The automated Bone Scan Index shows strong prognostic utility as an objective imaging biomarker for patients with metastatic castration-resistant…
Intensive chemotherapy may be more effective than alternative treatment for younger patients with myelodysplastic syndromes.
A longer duration of adjuvant chemotherapy may offer superior disease-free survival in patients with stage III colon cancer.

Conference Insider

Oncology Newswatch is providing coverage of a number of topics discussed at the 2018 ASCO Annual Meeting.